摘要
目的:研究米氮平与氟西汀治疗抑郁症的经济学效果。方法:将63例抑郁症患者随机分为米氮平组与氟西汀组,2组疗程均为6wk,运用药物经济学原理进行最小成本分析。结果:米氮平组与氟西汀组的有效率分别为86.7%、90.9%(P>0.05),治疗成本分别为2948.58、2845.30元。结论:氟西汀治疗抑郁症的经济学效果优于米氮平。
OBJECTIVE：To compare the economic efficacy between mirtazapine and fluoxetine in the treatment of depression. METHODS-A total of 63 patients with depression were assigned to receive mirtazapine or fluoxetine for 6 weeks, the cost - minimization analysis was performed using the theory of pharmacoeconomics.RESULTS＇The effective rate,the treatment cost of mirtazapine vs. fluoxetine were 86.7 % vs. 90.9 % （P 〉 0.05）, 2 948.58 vs. 2 845.30yuan, respectively. CONCLUSION ： Fluoxetine is superior to mirtazapine in terms of economic efficacy.
出处
《中国药房》
CAS
CSCD
北大核心
2007年第20期1527-1528,共2页
China Pharmacy
关键词
抑郁症
米氮平
氟西汀
最小成本分析
Depression
Mirtazapine
Fluoxetine
Cost - minimization analysis
